KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityLiabilities from Discontinued OperationsNon-Current AssetsOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsReceivables - OtherRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

TherapeuticsMD (TXMD) Total Non-Current Liabilities (2018 - 2025)

Historic Total Non-Current Liabilities for TherapeuticsMD (TXMD) over the last 10 years, with Q3 2025 value amounting to $10.4 million.

  • TherapeuticsMD's Total Non-Current Liabilities fell 1188.63% to $10.4 million in Q3 2025 from the same period last year, while for Sep 2025 it was $10.4 million, marking a year-over-year decrease of 1188.63%. This contributed to the annual value of $10.7 million for FY2024, which is 2000.6% down from last year.
  • As of Q3 2025, TherapeuticsMD's Total Non-Current Liabilities stood at $10.4 million, which was down 1188.63% from $10.4 million recorded in Q2 2025.
  • Over the past 5 years, TherapeuticsMD's Total Non-Current Liabilities peaked at $272.7 million during Q1 2022, and registered a low of $10.4 million during Q3 2025.
  • In the last 5 years, TherapeuticsMD's Total Non-Current Liabilities had a median value of $21.3 million in 2023 and averaged $90.4 million.
  • In the last 5 years, TherapeuticsMD's Total Non-Current Liabilities skyrocketed by 822.61% in 2021 and then plummeted by 9029.41% in 2023.
  • Quarter analysis of 5 years shows TherapeuticsMD's Total Non-Current Liabilities stood at $261.0 million in 2021, then tumbled by 79.23% to $54.2 million in 2022, then tumbled by 75.31% to $13.4 million in 2023, then decreased by 20.01% to $10.7 million in 2024, then fell by 3.29% to $10.4 million in 2025.
  • Its Total Non-Current Liabilities stands at $10.4 million for Q3 2025, versus $10.4 million for Q2 2025 and $10.7 million for Q1 2025.